DNA methylation at diagnosis is associated with response to disease-modifying drugs in early rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Epigenomics

• Publication date

  2017-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/epi-2016-0042PMID 27885849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid Arthritis

  2016cited by this paper
• Genome-wide profiling in treatment-naive early rheumatoid arthritis reveals DNA methylome changes in T and B lymphocytes.

  2016cited by this paper
• Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis

  2015cited by this paper
• CD8+ T Cell Profiles in Patients With Rheumatoid Arthritis and Their Relationship to Disease Activity

  2015cited by this paper
• Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis

  2015cited by this paper
• Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate

  2015cited by this paper
• Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications

  2015cited by this paper
• Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis

  2015cited by this paper
• Genetic and epigenetic predictors of responsiveness to treatment in RA

  2014cited by this paper
• Genome-wide DNA methylation profiling in rheumatoid arthritis identifies disease-associated methylation changes that are distinct to individual T- and B-lymphocyte populations

  2014cited by this paper
• Epigenetics in the pathogenesis of rheumatoid arthritis

  2014cited by this paper
• Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays

  2014cited by this paper
• The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis

  2013cited by this paper
• Epigenetic modifications in rheumatoid arthritis, a review.

  2013cited by this paper
• Epigenetics in Rheumatoid Arthritis: A Primer for Rheumatologists

  2013cited by this paper
• Combined influence of gene-specific cord blood methylation and maternal smoking habit on birth weight.

  2013cited by this paper
• The ascent of acetylation in the epigenetics of rheumatoid arthritis

  2013cited by this paper
• Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?

  2013cited by this paper
• Epigenome-wide profiling identifies significant differences in DNA methylation between matched-pairs of T- and B-lymphocytes from healthy individuals

  2013cited by this paper
• SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips

  2012cited by this paper
• Efficacy, Tolerability and Cost Effectiveness of Disease-Modifying Antirheumatic Drugs and Biologic Agents in Rheumatoid Arthritis

  2012cited by this paper
• Genome-scale case-control analysis of CD4+ T-cell DNA methylation in juvenile idiopathic arthritis reveals potential targets involved in disease

  2012cited by this paper
• The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response

  2012cited by this paper
• Butyrophilins: an emerging family of immune regulators.

  2012cited by this paper
• Remission in Early Rheumatoid Arthritis: Predicting Treatment Response

  2012cited by this paper
• High density DNA methylation array with single CpG site resolution.

  2011cited by this paper
• Reduction of Long-Term Disability in Inflammatory Polyarthritis by Early and Persistent Suppression of Joint Inflammation: Results From the Norfolk Arthritis Register

  2011cited by this paper
• Predictors of response to methotrexate in early DMARD naïve rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial

  2010cited by this paper
• Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis

  2010cited by this paper
• 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

  2010cited by this paper
• Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007.

  2010cited by this paper
• Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis

  2009cited by this paper
• Rheumatoid arthritis

  2009cited by this paper
• TGF-beta: a master of all T cell trades.

  2008cited by this paper
• Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.

  2008cited by this paper
• ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-β bioavailability regulation

  2008cited by this paper
• T cells in rheumatoid arthritis

  2008cited by this paper
• Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?

  2008cited by this paper
• Constitutive upregulation of the transforming growth factor-β pathway in rheumatoid arthritis synovial fibroblasts

  2007cited by this paper
• A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.

  2007cited by this paper
• Whole genome amplification of sodium bisulfite-treated DNA allows the accurate estimate of methylated cytosine density in limited DNA resources.

  2006cited by this paper
• Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.

  2006cited by this paper
• Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation.

  2004cited by this paper
• The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century.

  2002cited by this paper
• Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.

  2002cited by this paper
• DNA methylation patterns and epigenetic memory.

  2002cited by this paper
• Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

  2000cited by this paper
• Remission and response to early treatment of RA assessed by the Disease Activity Score. BARFOT study group. Better Anti-rheumatic Farmacotherapy.

  2000cited by this paper
• Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.

  1998cited by this paper
• DNA hypomethylation in inflammatory arthritis: reversal with methotrexate.

  1996cited by this paper
• Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.

  1996cited by this paper
• Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria.

  1996cited by this paper
• Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

  1995cited by this paper
• 'Touchdown' PCR to circumvent spurious priming during gene amplification.

  1991cited by this paper

• Dual Specificity Phosphatase (DUSP22) promoter hypomethylation in cell-free DNA is associated with rheumatoid arthritis and its radiographic severity.

  2026cites this paper
• Relationship periodontitis and Alzheimer's disease: Relevant aspects from an epigenetic view

  2025cites this paper
• Narrative review: translating DNA methylation in dementia.

  2025cites this paper
• Epigenetic modifications of immune cells in rheumatoid arthritis

  2025influential citation
• DNA methylation in human diseases

  2024cites this paper
• Methylation of T and B Lymphocytes in Autoimmune Rheumatic Diseases

  2024cites this paper
• Towards Personalized Medicine in Rheumatoid Arthritis

  2024cites this paper
• DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis

  2023cites this paper
• Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients

  2023cites this paper
• The prognostic value of whole-genome DNA methylation in response to Leflunomide in patients with Rheumatoid Arthritis

  2023cites this paper
• Identification of Cell‐Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid Arthritis

  2023influential citation
• Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

  2022cites this paper
• Circulating methylation level of HTR2A is associated with inflammation and disease activity in rheumatoid arthritis

  2022cites this paper
• -Omic Approaches and Treatment Response in Rheumatoid Arthritis

  2022cites this paper
• Expression of genes involved in epigenetic modifications in patients with rheumatoid arthritis

  2022cites this paper
• Transcriptome-Wide Association Studies and Integration Analysis of mRNA Expression Profiles Identify Candidate Genes and Pathways Associated With Ankylosing Spondylitis

  2022cites this paper
• Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook

  2021cites this paper
• ZNF718, HOXA4, and ZFP57 are differentially methylated in periodontitis in comparison with periodontal health: Epigenome-wide DNA methylation pilot study.

  2021cites this paper
• Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients

  2021cites this paper
• A review of Liquid biopsy as a tool to assess Epigenetic, cfDNA and miRNA variability as Methotrexate response predictors in patients with Rheumatoid Arthritis.

  2021cites this paper
• Methotrexate Treatment of Newly Diagnosed RA Patients Is Associated With DNA Methylation Differences at Genes Relevant for Disease Pathogenesis and Pharmacological Action

  2021influential citation
• Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets

  2021cites this paper
• Peripheral blood mononuclear cells are hypomethylated in active rheumatoid arthritis and methylation correlates with disease activity.

  2020cites this paper
• Epigenetic deregulation of immune cells in autoimmune and autoinflammatory diseases

  2020cites this paper
• Clinical value of DNA methylation markers in autoimmune rheumatic diseases

  2020cites this paper
• Epigenetic Regulation Mediated by Methylation in the Pathogenesis and Precision Medicine of Rheumatoid Arthritis

  2020cites this paper
• IDO and Kynurenine Metabolites in Peripheral and CNS Disorders

  2020cites this paper
• Understanding the Relevance of DNA Methylation Changes in Immune Differentiation and Disease

  2020cites this paper
• Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients

  2019cites this paper
• IDO activation, inflammation and musculoskeletal disease.

  2019cites this paper
• DNA methylation as a transcriptional regulator of the immune system

  2019cites this paper
• Changes in the NF‐&kgr;B signaling pathway in juvenile and adult patients with Kashin‐Beck disease

  2019cites this paper
• Epigenome-wide association studies for systemic autoimmune diseases: The road behind and the road ahead.

  2018cites this paper
• Hypomethylation of CYP2E1 and DUSP22 Promoters Associated With Disease Activity and Erosive Disease Among Rheumatoid Arthritis Patients

  2018cites this paper
• DNA methylation in human diseases

  2018cites this paper
• CpG-specific methylation at rheumatoid arthritis diagnosis as a marker of treatment response.

  2017cites this paper
• New insights into the epigenetics of inflammatory rheumatic diseases

  2017cites this paper
• Epigenetics of inflammatory arthritis

  2017cites this paper
• Epigenetics of the immune system and alterations in inflammation and autoimmunity.

  2017cites this paper
• Interplay between genetic and epigenetic mechanisms in rheumatoid arthritis.

  2017cites this paper